Laborde

Laborde Marine Acquires Two Deepwater Supply Vessels and Expands Fleet Under Management

Retrieved on: 
Thursday, January 12, 2023
OSV, Gulf of Mexico, Safety, Laborde, Knowledge, Maintenance, SOLAS, Acquisition, Oil

NEW ORLEANS, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Laborde Marine Management, LLC, (“Laborde Marine” or the “Company”) announced today that it has acquired two 240-foot deepwater DP-2 offshore supply vessels (“OSVs”) from L&M Botruc Rental, Inc. and has expanded its fleet of managed vessels.

Key Points: 
  • NEW ORLEANS, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Laborde Marine Management, LLC, (“Laborde Marine” or the “Company”) announced today that it has acquired two 240-foot deepwater DP-2 offshore supply vessels (“OSVs”) from L&M Botruc Rental, Inc. and has expanded its fleet of managed vessels.
  • The SHELLEY LAB and GIBSON LAB will fully support deepwater activities in the Gulf of Mexico and are SOLAS certified.
  • In total, Laborde Marine now has 34 vessels either owned or under management.
  • Along with the four new vessels we are also very pleased to welcome 43 new employees to our Laborde Marine family.

MultiCare Partners with IllumiCare to Offer Clinical Trials at Point-of-Care with Trials App

Retrieved on: 
Thursday, December 8, 2022
Innovation, EHR, Workflow, Research institute, Research, Patient, CRA, Laborde, MultiCare Health System, Hospital, Health, Clinical trial, Volunteering, MBA, Associate, Medical imaging, Pharmaceutical industry, Medical device, Inland Northwest

BIRMINGHAM, Ala., Dec. 8, 2022 /PRNewswire/ -- IllumiCare, a pioneer in point-of-care healthcare information technology, has partnered with MultiCare Health System to allow providers to recommend clinical trials as a therapeutic option at the point-of-care using its Trials App on the Smart Ribbon®. MultiCare is a not-for-profit healthcare organization with 11 hospitals in the state of Washington and has provided access to clinical trials through the MultiCare Institute for Research & Innovation for nearly 40 years. This is the first time the Trials App has been deployed in a clinical setting.

Key Points: 
  • MultiCare Health System is the first to use the app in a clinical setting, streamlining clinical trial recruitment and increasing awareness among providers, patients and clinical research teams.
  • BIRMINGHAM, Ala., Dec. 8, 2022 /PRNewswire/ -- IllumiCare , a pioneer in point-of-care healthcare information technology, has partnered with MultiCare Health System to allow providers to recommend clinical trials as a therapeutic option at the point-of-care using its Trials App on the Smart Ribbon.
  • This is the first time the Trials App has been deployed in a clinical setting.
  • MultiCare has introduced the Trials App to its oncology and pediatric providers, with plans to roll it out across other specialties next.

Trustmark and FHLB Dallas Award $750K for Affordable Housing

Retrieved on: 
Monday, November 7, 2022
Commercial Building & Real Estate, Construction & Property, Seniors, Urban Planning, Banking, Professional Services, General Health, Consumer, Health, Residential Building & Real Estate, Gulf Coast of the United States, Holiday Inn, Ageing, Multimedia, National Trust Community Investment Corporation, Federal Home Loan Bank Board, Congress, Movement, Trustmark, AHP, Rehabilitation, National bank, Income, FHLB, Housing, Partnership, Federal Home Loan Banks, Laborde, Real estate, Management, Pearl, Commercial Building & Real Estate, Construction & Property, Seniors, Urban Planning, Banking, Professional Services, General Health, Consumer, Health, Residential Building & Real Estate

Trustmark National Bank (Trustmark), the Federal Home Loan Bank of Dallas (FHLB Dallas), Gulf Coast Housing Partnership (GCHP) and others gathered this week to celebrate the groundbreaking of The Pearl, an affordable housing complex and healthcare clinic for older adults in Jackson, Mississippi.

Key Points: 
  • Trustmark National Bank (Trustmark), the Federal Home Loan Bank of Dallas (FHLB Dallas), Gulf Coast Housing Partnership (GCHP) and others gathered this week to celebrate the groundbreaking of The Pearl, an affordable housing complex and healthcare clinic for older adults in Jackson, Mississippi.
  • (Photo: Business Wire)
    Gulf Coast Housing Partnership received a $750,000 Affordable Housing Program (AHP) subsidy from Trustmark and FHLB Dallas to assist with the funding of the $28 million adaptive reuse project.
  • We are grateful for the partnership with FHLB Dallas to continue offering affordable housing.
  • In 2021, FHLB Dallas awarded $18.5 million in subsidies to 26 affordable housing projects to help create or rehabilitate 2,113 housing units, including $2.45 million for 234 units in Mississippi.

POINT Biopharma to Host Investor Education Event, “Understanding the PNT2002 Phase 3 SPLASH Trial Control Arm”, on August 18, 2022

Retrieved on: 
Monday, August 8, 2022
FDA, III, Prostate cancer, Dean (education), Clinical Genitourinary Cancer, Risk, United Kingdom, Forward-looking statement, GLOBE, ORR, Actinium-225, Private Securities Litigation Reform Act, SEC, Cancer, SPLASH, Medicine, Tulane University School of Medicine, NRG, Laborde, Research, Abiraterone acetate, Patient, NCI, Company, COVID-19, MCRPC, II, NASDAQ, Intention, GU, National Cancer Institute, Oncology, Docetaxel, BC Cancer Agency, MD, RPF, Clinical Science (journal), National, Pharmacokinetics, Terminology, Pharmaceutical industry, Medical imaging, Epidemiology

INDIANAPOLIS, Aug. 08, 2022 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating the discovery, development and global access to life-changing radiopharmaceuticals, announced that next week, on Thursday, August 18, 2022 at 12:00 PM ET, the Company will be presenting a 45-minute educational webinar entitled “Understanding the PNT2002 Phase 3 SPLASH Trial Control Arm”.

Key Points: 
  • He is also a past member of the National Cancer Institute Board of Scientific Counselors (Clinical Sciences and Epidemiology).
  • This includes phase I, II and III clinical trials, therapeutic use of antisense oligonucleotides and mechanisms of treatment resistance.
  • Information about POINT Biopharma Global Inc.s Phase 3 SPLASH trial for metastatic castrate resistant prostate cancer (mCRPC) patients can be found at https://www.splashtrial.com/ .
  • The forward-looking statements in this press release represent our views as of the date of this press release.

New Trials App Allows Providers to Recommend Clinical Trials as Therapeutic Option to Patients During Consultations

Retrieved on: 
Tuesday, May 3, 2022
Cros, EHR, Communication, Laborde, CEO, Technology, MD, Patient, App, Awareness, CMO, Clinical trial, Medical device, Pharmaceutical industry

BIRMINGHAM, Ala., May 3, 2022 /PRNewswire/ -- IllumiCare, a pioneer in point-of-care healthcare information technology, has automated the process of connecting patients to local or hybrid clinical trials during an appointment or consultation through its new Trials App on the Smart Ribbon®. 

Key Points: 
  • The Trials App, specifically, nudges providers in real-time if the patient they are seeing meets the referral criteria for an institutional clinical trial, as established by the local research team.
  • IllumiCare's Trials App is the first available tool that works within the existing EHR system to alert providers about trials matching their specific patient's criteria at the time most prime for the conversation about options, increasing their likelihood to join.
  • "The golden handoff in clinical trials occurs when a treating provider refers a patient to a local coordinator for follow-up.
  • Today, this is a painfully manual process, and the Trials App enables that process in a floating window, connecting all players within clinical trials into one seamless solution," said G.T.

IllumiCare Welcomes Ralph Keiser to Leadership Team as Chief Strategy Officer

Retrieved on: 
Tuesday, April 12, 2022
EPSI, CEO, Laborde, MDRX, HIT, Clinical trial, NASDAQ, Sale, ROP, Roper Technologies, Growth, List of life sciences, NYSE, Deloitte, Industry, Cerner, Management, Eclipsys, Allscripts

BIRMINGHAM, Ala., April 12, 2022 /PRNewswire/ -- IllumiCare, a pioneer in point-of-care healthcare information technology, today announces that Ralph Keiser has officially joined the company's leadership team as Chief Strategy Officer.

Key Points: 
  • BIRMINGHAM, Ala., April 12, 2022 /PRNewswire/ -- IllumiCare , a pioneer in point-of-care healthcare information technology, today announces that Ralph Keiser has officially joined the company's leadership team as Chief Strategy Officer.
  • In his new role, Keiser will be leading the development and execution of commercial strategy for 2022 and beyond.
  • IllumiCare is rapidly expanding its footprint in the industry, and I am excited to be a part of its growth and strategy development moving forward," said Keiser.
  • "This valuable executive addition to our team is yet another commitment that IllumiCare is prioritizing the advancement in the HIT and Life Science markets.

Affluent Medical : Successful first post-operative adjustment of KaliosTM mitral ring.

Retrieved on: 
Thursday, September 16, 2021
Adrenal insufficiency, Degenerative disease, Regulatory News Service, NYHA, ISIN, Urinary incontinence, Classification, Patient, Mitral insufficiency, Aix-en-Provence, Rest, Prognosis, Mitral valve repair, Death, Laborde, Heart failure, Recurrence, Myocardial infarction, Medical device, Health insurance, KALIOS, AFFLUENT MEDICAL

Affluent Medical : Successful first post-operative adjustment of KaliosTM mitral ring.

Key Points: 
  • Affluent Medical : Successful first post-operative adjustment of KaliosTM mitral ring.
  • Affluent Medical (ISIN: FR0013333077 - ticker: AFME), a French medtech specialising in the international development and industrial scale-up of innovative medical prostheses, at a clinical stage, to treat urinary incontinence and cardiac mitral insufficiency, today announces the success of the first ever KaliosTM mitral ring adjustment on a patient suffering from post-operative recurrence of severe mitral insufficiency.
  • Following successful implantation of a KaliosTM adjustable mitral ring, a simple trace of residual leakage was observed in a patient, who was operated in August 2020 for major mitral insufficiency (4+) [1] ,following a myocardial infarction.
  • Affluent Medical's Chief Medical Officer Prof. Franois Laborde confirmed that the KaliosTM device was a major breakthrough in treating mitral regurgitation and its recurrence, which happens between 30% and 40% of the redo mitral incompetence as reported in the medical literature.

Two Organizations Receive Nearly $1.3M to Renovate Homes and Build Apartments

Retrieved on: 
Wednesday, January 20, 2021
Other Philanthropy, Seniors, Construction & Property, Banking, Professional services, Philanthropy, Consumer, Residential Building & Real Estate, Federal Home Loan Banks, Mortgage industry of the United States, Alexandria, Louisiana, Geography of Louisiana, Rapides Parish, Louisiana, Laborde, LOUISIANA, Red River Bank, the Federal Home Loan Bank of Dallas

GRC plans to rehabilitate 50 homes owned by low-income seniors living in the Rapides Parish of Alexandria, Louisiana.

Key Points: 
  • GRC plans to rehabilitate 50 homes owned by low-income seniors living in the Rapides Parish of Alexandria, Louisiana.
  • Willie Spears, GRC executive director, said the AHP subsidy will help improve living conditions of low-income older residents.
  • We appreciate the funding support provided by Red River Bank and FHLB Dallas, said GCHP President and CEO Kathy Laborde.
  • Partnering with FHLB Dallas allows these organizations to provide their communities with the quality housing they deserve, she said.

Laborde Marine Expands Fleet Under Management

Retrieved on: 
Monday, October 7, 2019
Laborde

NEW ORLEANS, Oct. 07, 2019 (GLOBE NEWSWIRE) -- Laborde Marine Management, LLC, (Laborde Marine or the Company) announced that effective October 1st, the Company assumed the management of two vessels owned by Boat Services of Galveston, LLC.

Key Points: 
  • NEW ORLEANS, Oct. 07, 2019 (GLOBE NEWSWIRE) -- Laborde Marine Management, LLC, (Laborde Marine or the Company) announced that effective October 1st, the Company assumed the management of two vessels owned by Boat Services of Galveston, LLC.
  • With the addition of the MS MONICA, a 150 foot crewboat, and the TRISHA KAY, a 135 foot crewboat, Laborde Marine will have thirty vessels under management.
  • While these two additional vessels are not owned by Laborde Marine, all aspects of their operation ranging from providing outstanding, qualified crews, including Safety and Environmental Management Systems (SEMS) compliance, as well as supporting the mechanical and other systems, are provided by Laborde Marine.
  • Laborde Marine Management, LLC is based in New Orleans and owns or operates a fleet of 30 vessels which service the offshore oil industry and other marine support activities.

Aptos Welcomes Jeff Laborde to Lead Global Finance Efforts

Retrieved on: 
Wednesday, April 18, 2018
Economy, Laborde, Chief financial officer, Investment banking, Bank, Finance, Corporate finance, Aptos, California

LAS VEGAS, April 18, 2018 /PRNewswire/ --Aptos Engage 2018 Aptos, Inc. , a recognized market leader in retail technologysolutions, today announced the hiring of Jeff Laborde as finance leader.

Key Points: 
  • LAS VEGAS, April 18, 2018 /PRNewswire/ --Aptos Engage 2018 Aptos, Inc. , a recognized market leader in retail technologysolutions, today announced the hiring of Jeff Laborde as finance leader.
  • Laborde brings to Aptos more than 20 years of experience in corporate finance, M&A, public accounting and investment banking.
  • Prior to joining Aptos, Laborde held CFO roles at several private and publicly traded software companies including Accruent, Benefitfocus and Infor.
  • "I am excited to welcome Jeff to the Aptos family to lead our company's high-performing finance teams and to build upon our global financial framework," said Goggin.